title: New approaches to TB vaccination.
abstract: Pulmonary TB remains a leading global health issue, but the current Bacille Calmette-Guérin (BCG) vaccine fails to control it effectively. Much effort has gone into developing safe and effective boost vaccine candidates for use after the BCG prime vaccination. To date, almost all the lead candidates are being evaluated clinically via a parenteral route. Abundant experimental evidence suggests that parenteral boosting with a virus-based vaccine is much less effective than respiratory mucosal boosting, because the former fails to activate a type of T cell capable of rapidly transmigrating into the airway luminal space in the early phase of the Mycobacterium tuberculosis infection. The next few years will determine whether parenteral boosting with some of the lead vaccine candidates, particularly the protein-based vaccines, improves protection in humans over that by BCG. Much effort is needed to develop respiratory mucosal boost vaccines and to identify the reliable immune protective correlates in humans.
authors.affiliation: McMaster Immunology Research Centre, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada. Electronic address: xingz@mcmaster.ca.
authors.forename: Zhou
authors.initials: Z
authors.lastname: Xing
authors.affiliation: McMaster Immunology Research Centre, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
authors.forename: Mangalakumari
authors.initials: M
authors.lastname: Jeyanathan
authors.affiliation: McMaster Immunology Research Centre, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
authors.forename: Fiona
authors.initials: F
authors.lastname: Smaill
mesh_terms: D001500:BCG Vaccine / Q000276:immunology / Q000627:therapeutic use; D014943:Global Health; D006801:Humans; D007117:Immunization, Secondary; D032541:Mass Vaccination / Q000639:trends*; D032581:Tuberculosis Vaccines / Q000276:immunology / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000276:immunology / Q000517:prevention & control*
chemical_list: D001500:BCG Vaccine; D032581:Tuberculosis Vaccines